New York Times article today, June 17, 2013....states...
"Independent reviews of clinical trial data concluded that Infuse, a
bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks."
the article in full is in today's NY Times...
i am not expressing any opinion of my own...just quoting the article.
jess
"Independent reviews of clinical trial data concluded that Infuse, a
bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks."
the article in full is in today's NY Times...
i am not expressing any opinion of my own...just quoting the article.
jess
Comment